SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors
about
SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors
description
clinical trial
@en
klinisch onderzoek
@nl
name
SARC031: MEK Inhibitor Selumet ...... Peripheral Nerve Sheath Tumors
@en
type
label
SARC031: MEK Inhibitor Selumet ...... Peripheral Nerve Sheath Tumors
@en
prefLabel
SARC031: MEK Inhibitor Selumet ...... Peripheral Nerve Sheath Tumors
@en
P6153
P1476
SARC031: A Phase 2 Trial of th ...... Peripheral Nerve Sheath Tumors
@en
P3098
NCT03433183
P4844
P580
2019-04-01T00:00:00Z
P582
2021-09-01T00:00:00Z